{"resourceType": "Composition", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/summary-of-findings"], "versionId": "9", "lastUpdated": "2025-09-03T12:20:32.624Z"}, "title": "Summary of Findings - QUARTET USA Trial", "status": "final", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "SummaryOfFindings", "display": "SummaryOfFindings"}], "text": "Summary of Findings"}, "relatesTo": [{"type": "derived-from", "targetReference": {"reference": "Composition/375280", "type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial"}}, {"type": "cite-as", "targetMarkdown": "Summary of Findings - QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397488. Revised 2025-09-03. Available at: https://fevir.net/resources/Composition/397488. Computable resource at: https://fevir.net/resources/Composition/397488."}], "id": "397488", "url": "https://fevir.net/resources/Composition/397488", "date": "2025-09-03T12:20:32.624Z", "custodian": {"reference": "Organization/118079", "type": "Organization", "display": "Computable Publishing LLC"}, "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "397488", "assigner": {"display": "Computable Publishing LLC"}}], "author": [{"display": "Brian S. Alper, MD, MSPH"}], "text": {"status": "additional", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><tbody><tr><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div></th><th><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div></th></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Systolic blood pressure at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Diastolic blood pressure at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Medication Adherence at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>70%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.6%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>46.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Hypertension Control at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>54.17%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.52%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>77.11%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Add-on Amlodipine at 6 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>53.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>18.75%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>51.25%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Adverse event free and hypertension control at 12 weeks</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>33.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>17.24%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>29.33%</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div xmlns=\"http://www.w3.org/1999/xhtml\"><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr></tbody></table></div>"}, "section": [{"title": "Column Headers", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "column-headers", "display": "Column Headers"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">No need for narrative text.</div>"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div>"}}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div>"}}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div>"}}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div>"}}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div>"}}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div>"}}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div>"}}]}, {"title": "Summary of Findings", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings", "display": "Summary of Findings"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}, "section": [{"title": "Results for Systolic blood pressure at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375185", "type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Systolic blood pressure at 12 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375185", "type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"}, "entry": [{"reference": "Evidence/397483", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"reference": "Evidence/375594", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"reference": "Evidence/375628", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div>"}, "entry": [{"reference": "Evidence/397483", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397483", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397483", "type": "Evidence", "display": "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}, {"title": "Results for Diastolic blood pressure at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375186", "type": "EvidenceVariable", "display": "Diastolic blood pressure at 12 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Diastolic blood pressure at 12 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375186", "type": "EvidenceVariable", "display": "Diastolic blood pressure at 12 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"}, "entry": [{"reference": "Evidence/397482", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"reference": "Evidence/375932", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"}, "entry": [{"reference": "Evidence/375629", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div>"}, "entry": [{"reference": "Evidence/397482", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397482", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397482", "type": "Evidence", "display": "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}, {"title": "Results for Medication Adherence at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375201", "type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Medication Adherence at 12 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375201", "type": "EvidenceVariable", "display": "Medication Adherence at 12 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 without missing data</p></div>"}, "entry": [{"reference": "Evidence/397481", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>70%</p></div>"}, "entry": [{"reference": "Evidence/379724", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.6%</p></div>"}, "entry": [{"reference": "Evidence/379723", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div>"}, "entry": [{"reference": "Evidence/397481", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397481", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397481", "type": "Evidence", "display": "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}], "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Results for Hypertension Control at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375202", "type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Hypertension Control at 12 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375202", "type": "EvidenceVariable", "display": "Hypertension Control at 12 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"}, "entry": [{"reference": "Evidence/397480", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>54.17%</p></div>"}, "entry": [{"reference": "Evidence/379737", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.52%</p></div>"}, "entry": [{"reference": "Evidence/379736", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div>"}, "entry": [{"reference": "Evidence/397480", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397480", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397480", "type": "Evidence", "display": "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}, {"title": "Results for Add-on Amlodipine at 6 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375203", "type": "EvidenceVariable", "display": "Add-on Amlodipine at 6 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Add-on Amlodipine at 6 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375203", "type": "EvidenceVariable", "display": "Add-on Amlodipine at 6 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div>"}, "entry": [{"reference": "Evidence/397479", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>53.33%</p></div>"}, "entry": [{"reference": "Evidence/379740", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>18.75%</p></div>"}, "entry": [{"reference": "Evidence/379739", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div>"}, "entry": [{"reference": "Evidence/397479", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397479", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397479", "type": "Evidence", "display": "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}, {"title": "Results for Adverse event free and hypertension control at 12 weeks", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "summary-of-findings-entry-for-a-single-outcome", "display": "Summary of findings entry for a single outcome"}]}, "focus": {"reference": "EvidenceVariable/375278", "type": "EvidenceVariable", "display": "Adverse event free and hypertension control at 12 weeks"}, "section": [{"title": "Outcome Measure", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "outcome-measure", "display": "Outcome Measure"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Adverse event free and hypertension control at 12 weeks</p></div>"}, "entry": [{"reference": "EvidenceVariable/375278", "type": "EvidenceVariable", "display": "Adverse event free and hypertension control at 12 weeks"}]}, {"title": "Sample Size", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "sample-size", "display": "Sample Size"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div>"}, "entry": [{"reference": "Evidence/397478", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Result Without Treatment", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-comparator-alone", "display": "Result with comparator alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>33.33%</p></div>"}, "entry": [{"reference": "Evidence/379743", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group"}]}, {"title": "Result With Treatment--Observed", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone", "display": "Result with intervention alone"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>17.24%</p></div>"}, "entry": [{"reference": "Evidence/379742", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"}]}, {"title": "Result With Treatment--Derived", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-alone-calculated", "display": "Result with intervention alone (calculated)"}], "text": "result with intervention with calculated value derived from the control group and effect estimate"}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"}}, {"title": "Effect Estimate", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "result-with-intervention-vs-comparator", "display": "Result with intervention vs. comparator"}]}, "text": {"status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div>"}, "entry": [{"reference": "Evidence/397478", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Certainty of Evidence", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "certainty-of-evidence", "display": "Certainty of Evidence"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"}, "entry": [{"reference": "Evidence/397478", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}, {"title": "Assertion", "code": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "assertion", "display": "Assertion"}]}, "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"}, "entry": [{"reference": "Evidence/397478", "type": "Evidence", "display": "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"}]}]}]}]}